CompletedNot Applicable

Laryngeal Mask Airway (LMA) Insertion With Sevoflurane and Remifentanil

South Korea102 participantsStarted 2011-04

Plain-language summary

The purpose of this study was to determine the most suitable effect-site concentration of remifentanil for the LMA insertion during inhaled induction with 8% sevoflurane in adults.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- Adult patients, aged 18-60 with ASA physical status I or II, who were scheduled to minor elective surgery (\< 1 h) were considered for the study Exclusion Criteria: \- Exclusion criteria were allergies to the study drugs, a history of gastric reflux, a history of drug abuse, obesity (body mass index \> 30 kg/m2) and suspected difficult airway

What they're measuring

LMA Insertion Condition

Timeframe: at that time on LMA insertion only

Trial details

NCT IDNCT01456299

SponsorGachon University Gil Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-12

Results submitted2014-02-23

View on ClinicalTrials.gov More Laryngismus trials